Caffeine-Not just a stimulant

Nutrition

Volumn 26, Issue 10, 2010, Pages 932-938

  Glade, Michael J ^a  

^a NONE

Author keywords

Caffeine; Coffee; Cognitive function; Health promotion

Indexed keywords

CAFFEINE;

ADRENERGIC TRANSMISSION; ALERTNESS; ANXIETY; ATTENTION; BRAIN FUNCTION; COGNITION; DIETARY INTAKE; ENDURANCE; ENERGY BALANCE; ENERGY EXPENDITURE; FATIGUE; HUMAN; MENTAL CAPACITY; MENTAL HEALTH; MENTAL PERFORMANCE; MOOD; MOTOR COORDINATION; MOTOR PERFORMANCE; NEUROMUSCULAR SYSTEM; NUTRITIONAL HEALTH; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROBLEM SOLVING; PSYCHOPHYSIOLOGY; REVIEW; SHORT TERM MEMORY; SYNAPTIC TRANSMISSION; WAKEFULNESS;

ATTENTION; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; ENERGY METABOLISM; FATIGUE; HUMANS; MENTAL PROCESSES; PHYTOTHERAPY; PLANT EXTRACTS; PSYCHOMOTOR PERFORMANCE;

EID: 77957258032     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2010.08.004     Document Type: Review

References (101)

1. Biaggioni I., Paul S., Puckett A., Arzubiaga C. Caffeine and theophylline as adenosine receptor antagonists in humans. J Pharmacol Exp Ther 1991, 258:588-593.
2. Kalmar J.M., Cafarelli E. Effects of caffeine on neuromuscular function. J Appl Physiol 1999, 87:801-808.
3. Spraul M., Ravussin E., Fontvieille A.M., Rising R., Larson D.E., Anderson E.A. Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. J Clin Invest 1993, 92:1730-1735.
4. Dulloo A.G., Seydoux J., Girardierz L., Chantre P., Vandermander J. Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int J Obes 2000, 24:252-258.
5. Belza A., Toubro S., Astrup A. The effect of caffeine, green tea and tyrosine on thermogenesis and energy intake. Eur J Clin Nutr 2009, 63:57-64.
6. Hadjicharalambous M., Georgiades E., Kilduff L.P., Turner A.P., Tsofliou F., Pitsiladis Y.P. Influence of caffeine on perception of effort, metabolism and exercise performance following a high-fat meal. J Sports Sci 2006, 24:875-887.
7. Walton C., Kalmar J.M., Cafarelli E. Effect of caffeine on self-sustained firing in human motor units. J Physiol 2002, 545:671-679.
8. Hogervorst E., Bandelow S., Schmitt J., Jentjens R., Oliveira M., Allgrove J., et al. Caffeine improves physical and cognitive performance during exhaustive exercise. Med Sci Sports Exerc 2008, 40:1841-1851.
9. McClaran S.R., Wetter T.J. Low doses of caffeine reduce heart rate during submaximal cycle ergometry. J Int Soc Sports Nutr 2007, 4:11.
10. Doses and delivery mechanisms. Institute of Medicine Food and Nutrition Board committee on military nutrition research. Caffeine for the sustainment of mental task performance. Formulations for military operations 2001, 61-65. Institute of Medicine Food and Nutrition Board Committee on Military Nutrition Research, National Academy Press, Washington, DC.
11. Addicott M.A., Yang L.L., Peiffer A.M., Burnett L.R., Burdette J.H., Chen M.Y., et al. The effect of daily caffeine use on cerebral blood flow: how much caffeine can we tolerate?. Hum Brain Mapp 2009, 30:3102-3114.
12. Sigmon S.C., Herning R.I., Better W., Cadet J.L., Griffiths R.R. Caffeine withdrawal, acute effects, tolerance, and absence of net beneficial effects of chronic administration: cerebral blood flow velocity, quantitative EEG, and subjective effects. Psychopharmacology 2009, 204:573-585.
13. Bendlin B.B., Trouard T.P., Ryan L. Caffeine attenuates practice effects in word stem completion as measured by fMRI BOLD signal. Hum Brain Mapp 2007, 28:654-662.
14. Koppelstaetter F., Poeppel T.D., Siedentopf C.M., Ischebeck A., Verius M., Haala I., et al. Does caffeine modulate verbal working memory processes? An fMRI study. Neuroimage 2008, 39:492-499.
15. Lieberman H.R. Cognitive methods for assessing mental energy. Nutr Neurosci 2007, 10:229-242.
16. Hewlett P., Smith A. Effects of repeated doses of caffeine on performance and alertness: new data and secondary analyses. Hum Psychopharmacol 2007, 22:339-350.
17. Lieberman H.R., Wurtman R.J., Garfield G.S., Roberts C., Coviella I.L.G. The effects of low doses of caffeine on human performance and mood. Psychopharmacology 1987, 92:308-312.
18. Peeling P., Dawson B. Influence of caffeine ingestion on perceived mood states, concentration, and arousal levels during a 75-min university lecture. Adv Physiol Educ 2007, 31:332-335.
19. Kennedy M.D., Galloway A.V., Dickau L.J., Hudson M.K. The cumulative effect of coffee and a mental stress task on heart rate, blood pressure, and mental alertness is similar in caffeine-naïve and caffeine-habituated females. Nutr Res 2008, 28:609-614.
20. Hindmarch I., Rigney U., Stanley N., Quinlan P., Rycroft J., Lane J. A naturalistic investigation of the effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep quality. Psychopharmacology 2000, 149:203-216.
21. Smith A.P. Caffeine, cognitive failures and health in a non-working community sample. Hum Psychopharmacol 2009, 24:29-34.
22. Carrier J., Fernandez-Bolanos M., Robillard R., Dumont M., Paquet J., Selmaoui B., et al. Effects of caffeine are more marked on daytime recovery sleep than on nocturnal sleep. Neuropsychopharmacology 2007, 32:964-972.
23. Rao A., Hu H., Nobre A.C. The effects of combined caffeine and glucose drinks on attention in the human brain. Nutr Neurosci 2005, 8:141-153.
24. Smith A., Sutherland D., Christopher G. Effects of repeated doses of caffeine on mood and performance of alert and fatigued volunteers. J Psychopharmacol 2005, 19:620-626.
25. Christopher G., Sutherland D., Smith A. Effects of caffeine in non-withdrawn volunteers. Hum Psychopharmacol 2005, 20:47-53.
26. Haskell C.F., Kennedy D.O., Wesnes K.A., Scholey A.B. Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine. Psychopharmacology 2005, 179:813-825.
27. Heatherley S.V., Hayward R.C., Seers H.E., Rogers P.J. Cognitive and psychomotor performance, mood, and pressor effects of caffeine after 4, 6 and 8 h caffeine abstinence. Psychopharmacology 2005, 178:461-470.
28. Lieberman H.R., Wurtman R.J., Emde G.G., Coviella I.L.G. The effects of caffeine and aspirin on mood and performance. J Clin Psychopharmacol 1987, 7:315-320.
29. Philip P., Taillard J., Moore N., Delord S., Valtat C., Sagaspe P., et al. The effects of coffee and napping on nighttime highway driving: a randomized trial. Ann Intern Med 2006, 144:785-791.
30. Biggs S.N., Smith A., Dorrian J., Reid K., Dawson D., van den Heuvel C., et al. Perception of simulated driving performance after sleep restriction and caffeine. J Psychosom Res 2007, 63:573-577.
31. Tharion W.J., Shukitt-Hale B., Lieberman H.R. Caffeine effects on marksmanship during high-stress military training with 72 hour sleep deprivation. Aviat Space Environ Med 2003, 74:309-314.
32. McLellan T.M., Kamimori G.H., Bell D.G., Smith I.F., Johnson D., Belenky G. Caffeine maintains vigilance and marksmanship in simulated urban operations with sleep deprivation. Aviat Space Environ Med 2005, 76:39-45.
33. Safety of caffeine usage. Institute of Medicine Food and Nutrition Board committee on military nutrition research. Caffeine for the sustainment of mental task performance. Formulations for military operations 2001, 47-59. Institute of Medicine Food and Nutrition Board Committee on Military Nutrition Research, National Academy Press, Washington, DC.
34. Single ingredient monograph on caffeine December 31, 2007, Health Canada, Ottawa. Natural Health Products Directorate (Ed.).
35. Quinlan P., Lane J., Aspinall L. Effects of hot tea, coffee and water ingestion on physiological responses and mood: the role of caffeine, water and beverage type. Psychopharmacology 1997, 134:164-173.
36. Amendola C.A., Gabrieli J.D.E., Lieberman H.R. Caffeine's effects on performance and mood are independent of age and gender. Nutr Neurosci 1998, 1:269-280.
37. LaJambe C.M., Kamimori G.H., Belenky G., Balkin T.J. Caffeine effects on recovery sleep following 27 h total sleep deprivation. Aviat Space Environ Med 2005, 76:108-113.
38. Lieberman H.R., Tharion W.J., Shukitt-Hale B., Speckman K.L., Tulley R. Effects of caffeine, sleep loss, and stress on cognitive performance and mood during U.S. Navy SEAL training. Sea-Air-Land. Psychopharmacology 2002, 164:250-261.
39. Attwood A.S., Higgs S., Terry P. Differential responsiveness to caffeine and perceived effects of caffeine in moderate and high regular caffeine consumers. Psychopharmacology 2006, 190:469-477.
40. Bonita J.S., Mandarano M., Shuta D., Vinson J. Coffee and cardiovascular disease: in vitro, cellular, animal, and human studies. Pharmacol Res 2007, 55:187-198.
41. Paganini-Hill A., Kawas C.H., Corrada M.M. Non-alcoholic beverage and caffeine consumption and mortality: the Leisure World Cohort Study. Prev Med 2007, 44:305-310.
42. Happonen P., Läärä E., Hiltunen L., Luukinen H. Coffee consumption and mortality in a 14-year follow-up of an elderly northern Finnish population. Br J Nutr 2008, 99:1354-1361.
43. Sofi F., Conti A.A., Gori A.M., Eliana Luisi M.L., Casini A., Abbate R., et al. Coffee consumption and risk of coronary heart disease: a meta-analysis. Nutr Metab Cardiovasc Dis 2007, 17:209-223.
44. Center for Sceince in the Public Interest. Caffeine content of food and drugs. September 2007. Available at: Accessed September 10, 2010. http://www.cspinet.org/new/cafchart.htm.
45. Lopez-Garcia E., van Dam R.M., Willett W.C., Rimm E.B., Manson J.E., Stampfer M.J., et al. Coffee consumption and coronary heart disease in men and women: a prospective cohort study. Circulation 2006, 113:2045-2053.
46. Zhang W.L., Lopez-Garcia E., Li T.Y., Hu F.B., van Dam R.M. Coffee consumption and risk of cardiovascular events and all-cause mortality among women with type 2 diabetes. Diabetologia 2009, 52:810-817.
47. Lopez-Garcia E., van Dam R.M., Li T.Y., Rodriguez-Artalejo F., Hu F.B. The relationship of coffee consumption with mortality. Ann Intern Med 2008, 148:904-914.
48. Lopez-Garcia E., Rodriguez-Artalejo F., Rexrode K.M., Logroscino G., Hu F.B., van Dam R.M. Coffee consumption and risk of stroke in women. Circulation 2009, 119:1116-1123.
49. Andersen L.F., Jacobs D.R., Carlsen M.H., Blomhoff R. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nutr 2006, 83:1039-1046.
50. Greenberg J.A., Chow G., Ziegelstein R.C. Caffeinated coffee consumption, cardiovascular disease, and heart valve disease in the elderly (from the Framingham Study). Am J Cardiol 2008, 102:1502-1508.
51. Baylin A., Hernandez-Diaz S., Kabagambe E.K., Siles X., Campos H. Transient exposure to coffee as a trigger of a first nonfatal myocardial infarction. Epidemiology 2006, 17:506-511.
52. Martinez-Ortiz J.A., Fung T.T., Baylin A., Hu F.B., Campos H. Dietary patterns and risk of nonfatal acute myocardial infarction in Costa Rican adults. Eur J Clin Nutr 2006, 60:770-777.
53. Mukamal K.J., Maclure M., Muller J.E., Sherwood J.B., Mittleman M.A. Caffeinated coffee consumption and mortality after acute myocardial infarction. Am Heart J 2004, 147:999-1004.
54. Hamer M., Williams E.D., Vuononvirta R., Gibson E.L., Steptoe A. Association between coffee consumption and markers of inflammation and cardiovascular function during mental stress. J Hypertens 2006, 24:2191-2197.
55. Umemura T., Ueda K., Nishioka K., Hidaka T., Takemoto H., Nakamura S., et al. Effects of acute administration of caffeine on vascular function. Am J Cardiol 2006, 98:1538-1541.
56. Jee S.H., He J., Whelton P.K., Suh I., Klag M.J. The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension 1999, 33:647-652.
57. Noordzij M., Uiterwaal C.S., Arends L.R., Kok F.J., Grobbee D.E., Geleijnse J.M. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens 2005, 23:921-928.
58. Winkelmayer W.C., Stampfer M.J., Willett W.C., Curhan G.C. Habitual caffeine intake and the risk of hypertension in women. JAMA 2005, 294:2330-2335.
59. Giacomin E., Palmerini E., Ballo P., Zacà V., Bova G., Mondillo S. Acute effects of caffeine and cigarette smoking on ventricular long-axis function in healthy subjects. Cardiovasc Ultrasound 2008, 6:9.
60. Scholey A.B., Kennedy D.O. Cognitive and physiological effects of an " energy drink": an evaluation of the whole drink and of glucose, caffeine and herbal flavouring fractions. Psychopharmacology 2004, 176:320-330.
61. Vlachopoulos C.V., Vyssoulis G.G., Alexopoulos N.A., Zervoudaki A.I., Pietri P.G., Aznaouridis K.A., et al. Effect of chronic coffee consumption on aortic stiffness and wave reflections in hypertensive patients. Eur J Clin Nutr 2007, 61:796-802.
62. Vlachpopoulos C.V., Panagiotakos D., Ioakeimidis N., Dima I., Stefanadis Chronic coffee consumption has a detrimental effect on aortic stiffness and wave reflections. Am J Clin Nutr 2005, 81:1307-1312.
63. Uiterwaal C.S., Verschuren W.M., Bueno-de-Mesquita H.B., Ocke M., Geleijnse J.M., Boshuizen H.C., et al. Coffee intake and incidence of hypertension. Am J Clin Nutr 2007, 85:718-723.
64. Armstrong L.E., Casa D.J., Maresh C.M., Ganio M.S. Caffeine, fluid-electrolyte balance, temperature regulation, and exercise-heat tolerance. Exerc Sport Sci Rev 2007, 35:135-140.
65. Hamer M. Coffee and health: explaining conflicting results in hypertension. J Hum Hypertens 2006, 20:909-912.
66. Geleijnse J.M. Habitual coffee consumption and blood pressure: an epidemiological perspective. Vasc Health Risk Manag 2008, 4:963-970.
67. Funatsu K., Yamashita T., Nakamura H. Effect of coffee intake on blood pressure in male habitual alcohol drinkers. Hypertens Res 2005, 28:521-527.
68. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk: final rule. Fed Reg 2004, 69:6788-6854. Food and Drug Administration, Health and Human Services.
69. Turley K.R., Bland J.R., Evans W.J. Effects of different doses of caffeine on exercise responses in young children. Med Sci Sports Exerc 2008, 40:871-878.
70. Lopez-Garcia E., van Dam R.M., Qi L., Hu F.B. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr 2006, 84:888-893.
71. Williams C.J., Fargnoli J.L., Hwang J.J., van Dam R.M., Blackburn G.L., Hu F.B., et al. Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study. Diabetes Care 2008, 31:504-507.
72. Choi H.K., Willett W., Curhan G. Coffee consumption and risk of incident gout in men: a prospective study. Arthritis Rheum 2007, 56:2049-2055.
73. Kang J.H., Willett W.C., Rosner B.A., Hankinson S.E., Pasquale L.R. Caffeine consumption and the risk of primary open-angle glaucoma: a prospective cohort study. Invest Ophthalmol Vis Sci 2008, 49:1924-1931.
74. Tworoger S.S., Gertig D.M., Gates M.A., Hecht J.L., Hankinson S.E. Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer. Cancer 2008, 112:1169-1177.
75. Ganmaa D., Willett W.C., Li T.Y., Feskanich D., van Dam R.M., Lopez-Garcia E., et al. Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer 2008, 122:2071-2076.
76. Lueth N.A., Anderson K.E., Harnack L.J., Fulkerson J.A., Robien K. Coffee and caffeine intake and the risk of ovarian cancer: the Iowa Women's Health Study. Cancer Causes Control 2008, 19:1365-1372.
77. Song Y.J., Kristal A.R., Wicklund K.G., Cushing-Haugen K.L., Rossing M.A. Coffee, tea, colas, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2008, 17:712-716.
78. Lane J.D., Hwang A.L., Feinglos M.N., Surwit R.S. Exaggeration of postprandial hyperglycemia in patients with type 2 diabetes by administration of caffeine in coffee. Endocr Pract 2007, 13:239-243.
79. Lane J.D., Feinglos M.N., Surwit R.S. Caffeine increases ambulatory glucose and postprandial responses in coffee drinkers with type 2 diabetes. Diabetes Care 2008, 31:221-222.
80. MacKenzie T., Comi R., Sluss P., Keisari R., Manwar S., Kim J., et al. Metabolic and hormonal effects of caffeine: randomized, double-blind, placebo-controlled crossover trial. Metabolism 2007, 56:1694-1698.
81. Dekker M.J., Gusba J.E., Robinson L.E., Graham T.E. Glucose homeostasis remains altered by acute caffeine ingestion following 2 weeks of daily caffeine consumption in previously non-caffeine-consuming males. Br J Nutr 2007, 98:556-562.
82. Adeney K.L., Williams M.A., Schiff M.A., Qiu C., Sorensen T.K. Coffee consumption and the risk of gestational diabetes mellitus. Acta Obstet Gynecol Scand 2007, 86:161-166.
83. Salazar-Martinez E., Willett W.C., Ascherio A., Manson J.E., Leitzmann M.F., Stampfer M.J., Hu F.B. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 2004, 140:1-8.
84. Bech B.H., Obel C., Henriksen T.B., Olsen J. Effect of reducing caffeine intake on birth weight and length of gestation: randomised controlled trial. BMJ 2007, 24:334-409.
85. Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study. BMJ 2008, 337:a2332. CARE Study Group.
86. Weng X., Odouli R., Li D.K. Maternal caffeine consumption during pregnancy and the risk of miscarriage: a prospective cohort study. Am J Obstet Gynecol 2008, 198. 279.e1-8.
87. Mongraw-Chaffin M.L., Cohn B.A., Cohen R.D., Christianson R.E. Maternal smoking, alcohol consumption, and caffeine consumption during pregnancy in relation to a son's risk of persistent cryptorchidism: a prospective study in the Child Health and Development Studies cohort, 1959-1967. Am J Epidemiol 2008, 167:257-261.
88. Schmidt R.J., Romitti P.A., Burns T.L., Browne M.L., Druschel C.M., Olney R.S. National Birth Defects Prevention Study. Maternal caffeine consumption and risk of neural tube defects. Birth Defects Res A Clin Mol Teratol 2009, 85:879-889.
89. Kendler K.S., Myers J., O Gardner C. Caffeine intake, toxicity and dependence and lifetime risk for psychiatric and substance use disorders: an epidemiologic and co-twin control analysis. Psychol Med 2006, 36:1717-1725.
90. Whalen D.J., Silk J.S., Semel M., Forbes E.E., Ryan N.D., Axelson D.A., et al. Caffeine consumption, sleep, and affect in the natural environments of depressed youth and healthy controls. J Pediatr Psychol 2008, 33:358-367.
91. Nardi A.E., Lopes F.L., Freire R.C., Veras A.B., Nascimento I., Valença A.M., et al. Panic disorder and social anxiety disorder subtypes in a caffeine challenge test. Psychiatry Res 2009, 169:149-153.
92. Ritchie K., Carrière I., de Mendonca A., Portet F., Dartigues J.F., Rouaud O., et al. The neuroprotective effects of caffeine: a prospective population study (the Three City Study). Neurology 2007, 69:536-545.
93. Eskelinen M.H., Ngandu T., Tuomilehto J., Soininen H., Kivipelto M. Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. J Alzheimers Dis 2009, 16:85-91.
94. Tan E.K., Chua E., Fook-Chong S.M., Teo Y.Y., Yuen Y., Tan L., et al. Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers. Pharmacogenet Genomics 2007, 17:1001-1005.
95. Sääksjärvi K., Knekt P., Rissanen H., Laaksonen M.A., Reunanen A., Männistö S. Prospective study of coffee consumption and risk of Parkinson's disease. Eur J Clin Nutr 2008, 62:908-915.
96. Dworetzky B.A., Bromfield E.B., Townsend M.K., Kang J.H. A prospective study of smoking, caffeine, and alcohol as risk factors for seizures or epilepsy in young adult women: Data from the Nurses' Health Study II. Epilepsia 2010, 51:198-205.
97. Hagen K., Thoresen K., Stovner L.J., Zwart J.A. High dietary caffeine consumption is associated with a modest increase in headache prevalence: results from the Head-HUNT Study. J Headache Pain 2009, 10:153-159.
98. Killgore W.D., Rupp T.L., Grugle N.L., Reichardt R.M., Lipizzi E.L., Balkin T.J. Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness. J Sleep Res 2008, 17:309-321.
99. Killgore W.D., Grugle N.L., Killgore D.B., Leavitt B.P., Watlington G.I., McNair S., et al. Restoration of risk-propensity during sleep deprivation: caffeine, dextroamphetamine, and modafinil. Aviat Space Environ Med 2008, 79:867-874.
100. Killgore W.D., Kahn-Greene E.T., Grugle N.L., Killgore D.B., Balkin T.J. Sustaining executive functions during sleep deprivation: a comparison of caffeine, dextroamphetamine, and modafinil. Sleep 2009, 32:205-216.
101. Killgore W.D., Lipizzi E.L., Kamimori G.H., Balkin T.J. Caffeine effects on risky decision making after 75 hours of sleep deprivation. Aviat Space Environ Med 2007, 78:957-962.